SCHEMBL1298196

SCHEMBL1298196

Oc1coccc1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13024045 0.68
SCHEMBL588597 0.68
SCHEMBL6021918 0.67
SCHEMBL10489061 0.67
Hydrochloric Acid SCHEMBL22711054 0.67 MMP2 (0.50)
SCHEMBL7712387 0.67
SCHEMBL6665441 0.67 MMP2 (0.50)
SCHEMBL242033 0.65
Hydrochloric Acid SCHEMBL28821640 0.63
Methane SCHEMBL1523810 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 US claimed
EP-2710119-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION Cleave Biosciences, Inc. (US) 2014-03-26 EP claimed
WO-2012158435-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION ZHOU HAN-JIE (US) 2012-11-22 WO claimed
US-20120276152-A1 SYSTEMS AND METHODS OF USING ZINC-CHELATOR TO TREAT MYOCARDIAL INFARCTION ABBOTT CARDIOVASCULAR SYSTEMS INC., 2012-11-01 US claimed
US-7576213-B2 Vinylogous 4H-pyrones and their use in promoting plant growth THE UNIVERSITY OF WESTERN AUSTRALIA (AU) 2009-08-18 US claimed
US-20070105721-A1 Vinylogous 4-Hpyrones and their use in promoting plant growth THE UNIVERSITY OF WESTERN AUSTRALIA (AU) 2007-05-10 US claimed
WO-2005061515-A1 VINYLOGOUS 4H-PYRONES AND THEIR USE IN PROMOTING PLANT GROWTH BOTANICAL GARDENS AND PARKS AUTHORITY (AU) 2005-07-07 WO claimed
US-11021471-B2 Antibacterial compounds FORGE THERAPEUTICS, INC. (US) 2021-06-01 US disclosed
US-11014871-B2 “Multi-target” compounds with inhibitory activity towards histone deacetylases and tubulin polymerisation, for use in the treatment of cancer CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2021-05-25 US disclosed
US-10918106-B2 Methods for hydraulic enhancement of crops Sound Agriculture Company (US) 2021-02-16 US disclosed
US-20200255413-A1 ANTIBACTERIAL COMPOUNDS BLACKSMITH MEDICINES, INC. 2020-08-13 US disclosed
US-20200087648-A1 PARKIN LIGASE ACTIVATION METHODS AND COMPOSITIONS NYSNOBIO IRELAND DAC (IE) 2020-03-19 US disclosed
EP-3621962-A2 ANTIBACTERIAL COMPOUNDS Forge Therapeutics, Inc. (US) 2020-03-18 EP disclosed
US-20060199826-A1 Cyclopropane compounds and pharmaceutical use thereof JAPAN TOBACCO INC. (JP) 2006-09-07 US disclosed
EP-1694638-A1 N-SUBSTITUTED-N-SULFONYLAMINOCYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2006-08-30 EP disclosed
EP-1694410-A2 CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2006-08-30 EP disclosed
US-20050222146-A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof JAPAN TOBACCO INC. (JP) 2005-10-06 US disclosed
WO-2005061515-A1 VINYLOGOUS 4H-PYRONES AND THEIR USE IN PROMOTING PLANT GROWTH BOTANICAL GARDENS AND PARKS AUTHORITY (AU) 2005-07-07 WO disclosed
WO-2005058808-A1 N-SUBSTITUTED-N-SULFONYLAMINOCYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-06-30 WO disclosed
WO-2005058884-A2 CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-06-30 WO disclosed